BPC-157 Side Effects & Safety Reported side effects fall into three buckets: directly observed effects in pilot studies, theoretical risks based on mechanism, and route-specific issues
At the end of the SURMOUNT-4 study (88 weeks from baseline), 25.9% of people at the placebo group were able to achieve 15% WL compared to 84.1% at the tirzepatide group
If you are coming from the other direction, we also have resources on switching from tirzepatide to semaglutide and the complete semaglutide to tirzepatide conversion chart
**It is also important to know that we source organic ingredients as often as possible for our products, therefore, we do not add any preservatives to our products
Most nausea is mild to moderate and occurs during dose escalation
Both GLP-1(7-36) amide and the GLP-1 receptor agonist, exendin-4 are shown to increase heart rate and blood pressure in both anesthetized and conscious restrained rats, although the mechanisms are controversial [22, 23]